Observational studyMicrobiology spectrum2026
Bacteremia evaluation with T2 magnetic resonance in the emergency room (BETTER).
Observational study in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Conventional blood culture (BC) is limited by long turnaround times and low sensitivity. The T2Bacteria is a novel culture-independent system identifying six bacteria from whole blood within a few hours. We conducted an observational study in an Australian Emergency Department to assess the performance of T2Bacteria, including its diagnostic accuracy, time to results, and potential role in early adjustment of antimicrobials. Patients with suspected bacteremia were enrolled and had BC drawn with T2Bacteria samples. We enrolled 101 patients. Thirty-five patients had positive BC, of which 31 (88.5%) grew T2Bacteria on-panel pathogens. Eight patients (26%) grew T2Bacteria on-panel pathogens in BC but had negative T2Bacteria results. Agreement between T2Bacteria and BC for T2Bacteria on-panel pathogens was 87.6%, sensitivity was 70.4%, and specificity 94.3%. Median time to results for T2Bacteria was 8.7 h, IQR 7.2-9.6, significantly shorter than time to Gram stain (17.0 h, IQR 12.2-21.6,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.